This is an industrial turning point for ImmunoSearch. Born in 2007 as part of the competitiveness clusters, the Grasse-based company which works on the health safety of perfume and cosmetic ingredients, and more generally all products in contact with the skin, is growing.
Installed over 240m2chemin de Camperousse, in Plan de Grasse, the company with a turnover of 1 million euros in 2023 has doubled its surface area.
By installing a new 250m laboratory on the same floor2. “From a research activity, we extend to a production activity”, explains its president Hervé Groux at the time of the inauguration of these new premises in the presence of the mayor of Grasse Jérôme Viaud.
An investment of €250,000 including €140,000 subsidized by the Region.
Growth in one month
“We offer an alternative to animal testing by working on human skin. We are the only ones in the world to offer these in vitro tests for skin and eye irritation. Until now, we purchased skin from biopsies following surgical operations. In our new laboratory, we will produce them. It costs less to produce than to buy.”
From cell culture, human skin grows in one month.
ImmunoSearch tests allow us to know at what precise dosage a product can be toxic to the epidermis.
Mane: “We’re saving time”
“Thanks to these technologies, we save time in product development” comments Eric Angelini at Mane.
Hervé Groux also specifies “working on non-genotoxic carcinogenesis, the capacity of a product to have an impact on the occurrence of cancers”.
Building on its position as a technological leader, ImmunoSearch is focused on ambitious international development.
In 2023, the global in vitro toxicology testing market size was estimated at $30 billion.
And is expected to reach 64 billion by 2030…
